
Company Info
Year Established2023
Contacts
Jonathan Drachman, MDCo-Founder & CEO
Company Description
StradBio is creating the next generation of immunotherapies for cancer and inflammatory diseases. Through precision-tuned cytokine mimetics, targeting, and logic gates, they are building drugs that can deliver potent activation of immune cells where they are needed most, minimizing side effects.